1. Preventions
1.1. Integrated Vector Management (IVM) by WHO
2. Treatment
3. Diagnosis
3.1. Anamnesis
3.2. Physixal Examination
3.3. Supporting Examination
4. Managemnet
4.1. Pharmacological
4.2. Non-pharmacological
5. Prognosis
6. Nnn
6.1. Jjjj
7. Etiology
7.1. Causes
7.1.1. DENV (Dengue Virus)
7.1.1.1. Type of Dengue Virus
7.1.1.1.1. DENV1
7.1.1.1.2. DENV2
7.1.1.1.3. DENV3
7.1.1.1.4. DENV4
7.1.1.2. Family
7.1.1.2.1. Flaviviridae
7.1.1.3. Genus
7.1.1.3.1. Flavivirus
8. Clinical Manifestations
8.1. DENV Serotype
8.1.1. DENV 1
8.1.1.1. Symptoms
8.1.1.1.1. Fever
8.1.1.1.2. Headache
8.1.1.1.3. Pain
8.1.1.1.4. Rash
8.1.2. DENV 2
8.1.2.1. DHF
8.1.2.1.1. Plasma leakgae
8.1.2.2. DSS
8.1.3. DENV 3
8.1.4. DENV 4
9. Epidemiology
9.1. Transmission
9.1.1. Mosquitoes
9.1.1.1. Aedes aegypti
9.1.1.2. Aedes Albopictus
9.2. Prevalence
9.2.1. Tropical and subtropical regions
9.2.1.1. 100 countries
10. Pathophysiology
10.1. Mechanism
10.1.1. Bite of Aedes aegypti
10.1.1.1. Virus penterates to skin
10.1.1.1.1. Replicates
10.1.2. 2
10.2. Cells Affected
11. Symptoms
11.1. Dengue Fever Phase
11.1.1. Febrile Phase
11.1.1.1. Mild Symptoms
11.1.1.1.1. High Fever
11.1.1.1.2. Severe Headache
11.1.1.1.3. Muscle and Joint Pain
11.1.1.1.4. Nausea
11.1.1.1.5. Vommit
11.1.1.1.6. Rash
11.1.1.2. Period
11.1.2. Crtitical Phase
11.1.2.1. Severe Symptoms
11.1.2.2. Period
11.1.3. Recovery Phase
11.1.3.1. Symptoms
11.1.3.2. Period
12. Complication
12.1. Dengue Hemorrhagic Fever (DHF)
12.1.1. Vvv